Author | James M. Rossetti, DO | OncLive

Author | James M. Rossetti, DO

Articles

Dr. Rossetti on the Utility of JAK Inhibitors in MPNs

April 22, 2020

Video

James M. Rossetti, DO, discusses the utility of JAK inhibitors in myeloproliferative neoplasms.

Dr. Rossetti on the Fast Track Designation of Momelotinib in Myelofibrosis

April 10, 2020

Video

James M. Rossetti, DO, discusses the FDA’s decision to grant momelotinib a fast track designation for use in patients with intermediate- or high-risk myelofibrosis who previously received a JAK inhibitor.

Dr. Rossetti on Symptom Management for MPNs

February 27, 2020

Video

James M. Rossetti, DO, discusses symptom management for patients with myeloproliferative neoplasms.

Dr. Rossetti on Symptom Management for Patients With MPNs

February 22, 2020

Video

James M. Rossetti, DO, discusses symptom management for patients with myeloproliferative neoplasms.

x